The stimulatory effect of vasopressin on the luteinizing hormone surge in ovariectomized, estradiol-treated rats is time-dependent.
The luteinizing hormone surge in the female rat is not only induced by the positive feedback of estradiol, but also by circadian signals originating in the suprachiasmatic nucleus (SCN). In a previous study we showed that administration of vasopressin, an SCN transmitter present in preoptic projections, induced an LH surge in animals bearing complete lesions of the SCN. This strongly suggests vasopressin as a stimulatory circadian signal for the timing of the LH surge. In the present study we investigated during which time window vasopressin may act in the medial preoptic area to stimulate LH secretion in SCN-intact female rats. Vasopressin or a specific V1a receptor antagonist was administered into the MPO by a reverse microdialysis technique during different time windows, and plasma LH concentrations were measured. Vasopressin stimulated the LH surge in 30% of the animals, when administered during the second half of the light period, but during the first half of the light period no effects were observed. Administration of the V1a receptor antagonist, however, did not affect the LH surge. These data confirm our previous results that vasopressin is a stimulatory factor for the LH surge also in SCN-intact animals, and indicate that a certain time window is available for such stimulation. We hypothesize that vasopressin in the SCN-intact animal may act as a circadian signal during a specific time window to induce the LH surge. The time window is the result of other SCN regulatory systems that are involved in the preparation of the LH surge.
Palm
I F
IF
Netherlands Institute for Brain Research, Meibergdreef 33, 1105 AZ, Amsterdam, The Netherlands. inge.palm@numico-research.nl
van der Beek
E M
EM
Wiegant
V M
VM
Buijs
R M
RM
Kalsbeek
A
A
D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D002940:Circadian Rhythm / Q000187:drug effects* / Q000502:physiology; D004958:Estradiol / Q000097:blood / Q000494:pharmacology; D004971:Estrus / Q000187:drug effects* / Q000502:physiology; D005260:Female; D007986:Luteinizing Hormone / Q000097:blood* / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D010052:Ovariectomy; D011301:Preoptic Area / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D017483:Receptors, Vasopressin / Q000378:metabolism; D013493:Suprachiasmatic Nucleus / Q000378:metabolism; D013997:Time Factors; D014667:Vasopressins / Q000378:metabolism / Q000494:pharmacology*
D065092:Antidiuretic Hormone Receptor Antagonists; D017483:Receptors, Vasopressin; D014667:Vasopressins; D004958:Estradiol; D007986:Luteinizing Hormone